PCM
JAZZ icon

Polaris Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Polaris Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.5M Sell
415,366
-17,100
-4% -$2.99M 6.42% 2
2025
Q4 		$73.5M Sell
432,466
-81,000
-16% -$12.4M 6.1% 2
2025
Q3 		$67.7M Sell
513,466
-120,694
-19% -$14.5M 4.45% 5
2025
Q2 		$67.3M Sell
634,160
-245,000
-28% -$26.6M 4.48% 5
2025
Q1 		$109M Sell
879,160
-206,700
-19% -$27M 6.24% 5
2024
Q4 		$134M Sell
1,085,860
-219,700
-17% -$25.9M 6.45% 4
2024
Q3 		$145M Sell
1,305,560
-69,900
-5% -$7.66M 7.17% 3
2024
Q2 		$147M Sell
1,375,460
-57,200
-4% -$6.29M 7.87% 3
2024
Q1 		$173M Buy
1,432,660
+165,200
+13% +$20.2M 8.6% 3
2023
Q4 		$156M Buy
1,267,460
+27,100
+2% +$3.38M 7.53% 3
2023
Q3 		$161M Sell
1,240,360
-56,300
-4% -$7.5M 8.65% 2
2023
Q2 		$161M Sell
1,296,660
-11,200
-0.9% -$1.51M 6.04% 2
2023
Q1 		$191M Buy
1,307,860
+54,500
+4% +$8.06M 7.14% 2
2022
Q4 		$200M Sell
1,253,360
-217,100
-15% -$31.8M 6.95% 2
2022
Q3 		$196M Sell
1,470,460
-7,800
-0.5% -$1.19M 7.69% 2
2022
Q2 		$231M Sell
1,478,260
-25,700
-2% -$3.96M 8.24% 2
2022
Q1 		$234M Sell
1,503,960
-8,500
-0.6% -$1.23M 7.44% 2
2021
Q4 		$193M Sell
1,512,460
-450,303
-23% -$59.2M 6.21% 4
2021
Q3 		$256M Buy
1,962,763
+670,003
+52% +$101M 8.15% 2
2021
Q2 		$230M Buy
+1,292,760
New +$224M 7.41% 2

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Polaris Capital Management's JAZZ Position: Q1 2026 in Review

Polaris Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 4% in Q1 2026, selling an estimated $2.99M and leaving 415,366 shares worth $78.5M. The position accounts for 6.42% of the portfolio, ranked #2.

Polaris Capital Management first reported a position in JAZZ in Q2 2021 and has held it in 20 quarters since. The position peaked at $256M in Q3 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Polaris Capital Management held 415,366 shares of Jazz Pharmaceuticals worth $78.5M as of Q1 2026.
  • Polaris Capital Management sold 17,100 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.99M.
  • Jazz Pharmaceuticals made up 6.42% of Polaris Capital Management's portfolio in Q1 2026, its #2 holding.
  • Polaris Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Polaris Capital Management's Jazz Pharmaceuticals position peaked at $256M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Polaris Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.